COMMUNIQUÉS West-GlobeNewswire

FDA grants Priority Review for Roche’s Tecentriq for a certain type of stage III colon cancer
11/06/2026
Filing acceptance is based on the phase III Alliance ATOMIC study showing Tecentriq plus chemotherapy reduced recurrence or death risk by 50% versus chemotherapy alone 1 Nearly one in three patients with stage III colon [...]
Glass House Brands Announces the Filing of Shelf Prospectus and At-The-Market Distribution Program
11/06/2026
LONG BEACH, Calif. and TORONTO, June 10, 2026 (GLOBE NEWSWIRE) -- Glass House Brands Inc. (“ Glass House ” or the “ Company ”) (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX:GHBWF) announced today that [...]
Tilray Medical Allemagne lance ARX™, une nouvelle marque de cannabis médicinal haut de gamme cultivé en Allemagne
11/06/2026
La nouvelle marque associe des variétés éprouvées, l’expertise allemande en matière de culture et des normes de qualité rigoureuses au service des patients et des professionnels de santé dans toute l’Allemagne [...]
CARPL.ai Partners with Enlitic to Accelerate AI Validation for Imaging Customers
11/06/2026
CUPERTINO, Calif., June 10, 2026 (GLOBE NEWSWIRE) -- CARPL.ai, the world's largest radiology AI marketplace and enterprise platform, today announced a partnership with Enlitic, to give imaging customers a stronger [...]
Humacyte, Inc. Announces Pricing of Public Offering of Common Stock
11/06/2026
DURHAM, N.C., June 10, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today [...]
Humacyte, Inc. Announces Proposed Public Offering of Common Stock
11/06/2026
DURHAM, N.C., June 10, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today [...]
SafeSpace Global Announces Launch of New Addiction Treatment Vertical, Supported by Signed Master Services Agreement and Conditional $2 Million Funding Commitment
10/06/2026
KNOXVILLE, TN, June 10, 2026 (GLOBE NEWSWIRE) -- SafeSpace Global Corporation (“SafeSpace Global” or the “Company”), a provider of AI-powered physical safety and security solutions for regulated care environments, today [...]
Transactions of Managers and Closely Associated Persons
10/06/2026
Attached is a copy of a filing with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding a transaction of managers and closely associated persons, announcing the allocation of shares to a [...]
Nyxoah Annonce la Clôture de l'Offre
10/06/2026
INFORMATIONS RÉGLEMENTÉES Nyxoah Annonce la Clôture de l'Offre Mont-Saint-Guibert, Belgique – 10 juin 2026, 22h05 CET / 16h05 ET - Nyxoah SA (Euronext Brussels/Nasdaq : NYXH) (« Nyxoah » ou la « Société »), une société [...]
Nova Leap Health Corp. Announces Results of Annual and Special Meeting of Shareholders
10/06/2026
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, June 10, 2026 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), [...]
$110 Million in Aggregate Financings to Accelerate Genio's U.S. Commercial Launch
10/06/2026
$110 Million in Aggregate Financings to Accelerate Genio's U.S. Commercial Launch Mont-Saint-Guibert, Belgium – June 10, 2026, 10:30 pm CET / 04:30 pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “ [...]
Tectonic Therapeutic Completes Enrollment in TX45 APEX Phase 2 Clinical Trial in PH-HFpEF Patients
10/06/2026
APEX 24-week Phase 2 trial is evaluating the safety and efficacy of TX45 in patients with pulmonary hypertension associated with heart failure with preserved ejection fraction (PH-HFpEF) APEX Phase 2 trial enrolled 191 [...]
Humacyte ATEV Met Superiority Primary Endpoint Compared to Standard of Care AV Fistula in Interim Analysis of V012 Phase 3 Study in Female Dialysis Access Patients
10/06/2026
- Humacyte plans to file a supplemental Biologic License Application (BLA) with the Food and Drug Administration (FDA) during the second half of 2026 - - The ATEV met V012’s primary endpoint and was observed to have [...]
Cytek Biosciences to participate at the Singular Research’s Las Vegas Invitational Conference
10/06/2026
FREMONT, Calif., June 10, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced that the company will be participating in the upcoming Singular [...]
Humacyte, Inc. Announces Proposed Public Offering of Common Stock
10/06/2026
DURHAM, N.C., June 10, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today [...]
Celldex Announces Multiple Upcoming Presentations from Leading Mast Cell Targeting Pipeline at the Upcoming 2026 European Academy of Allergy and Clinical Immunology Annual Congress
10/06/2026
-- Flash talks on barzolvolimab clinical program in CSU and Cold Urticaria -- -- Late-breaking poster presentation on CDX-622 -- HAMPTON, N.J., June 10, 2026 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) announced today [...]
Informations sur le nombre total de droits de vote et d'actions
10/06/2026
INFORMATION RÉGLEMENTÉE Informations sur le nombre total de droits de vote et d'actions Mont-Saint-Guibert (Belgique), le 10 juin 2026, 23h00 CET / 17h00 ET – Conformément à l'article 15 de la loi du 2 mai 2007 relative [...]
Exicure Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders’ Equity Requirement
10/06/2026
WILMINGTON, Del., June 10, 2026 (GLOBE NEWSWIRE) -- Exicure, Inc. (Nasdaq: XCUR) (the “Company”) today announced that it received a notification letter from the Listing Qualifications Department of The Nasdaq Stock [...]
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
10/06/2026
Company announcement – No. 24 / 2026 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, June [...]

Pages